WEDNESDAY, Jan. 8, 2025 (HealthDay News) — Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been approved for that purpose. A new evidence review published in the Annals of Internal Medicine shows that the widely-known drugs tirzepatide (Zepbound) and semaglutideContinue Reading

TUESDAY, Jan. 7, 2025 (HealthDay News) — The U.S. Food and Drug Association (FDA) released the first-ever guidelines for levels of lead in processed baby foods this week. However, many health and safety advocates say they are not satisfied with the guidance. Under the FDA’s new guidelines, baby food manufacturersContinue Reading